Group One Trading
TARS icon

Group One Trading’s Tarsus Pharmaceuticals TARS Stock Holding History

Group One Trading’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$49.1K Buy
+700
New +$48.9K ﹤0.01% 5269
2025
Q4 		– Sell
-500
Closed -$29.7K – 9134
2025
Q3 		$29.7K Sell
500
-1,700
-77% -$83.7K ﹤0.01% 6378
2025
Q2 		$89.1K Sell
2,200
-3,600
-62% -$162K ﹤0.01% 5073
2025
Q1 		$298K Sell
5,800
-2,300
-28% -$114K ﹤0.01% 3597
2024
Q4 		$448K Sell
8,100
-16,300
-67% -$740K ﹤0.01% 3263
2024
Q3 		$803K Buy
24,400
+11,400
+88% +$320K ﹤0.01% 2487
2024
Q2 		$353K Buy
13,000
+3,400
+35% +$114K ﹤0.01% 2886
2024
Q1 		$349K Buy
9,600
+400
+4% +$11.8K ﹤0.01% 3072
2023
Q4 		$186K Buy
+9,200
New +$154K ﹤0.01% 3930
2023
Q1 		– Sell
-8,500
Closed -$125K – 7948
2022
Q4 		$125K Buy
+8,500
New +$141K ﹤0.01% 4240

Other funds holding TARS

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Group One Trading's TARS Position: Q4 2025 in Review

Group One Trading sold out of Tarsus Pharmaceuticals (TARS) in Q4 2025, closing a stake of 1,163 shares — an estimated $69.1K sold.

Group One Trading first reported a position in TARS in Q1 2025 and held it in 3 quarters. The position peaked at $69.1K in Q3 2025. 246 funds tracked by Wall St. Rank hold TARS as of Q4 2025.

  • Group One Trading reported no remaining Tarsus Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 1,163 Tarsus Pharmaceuticals shares in Q4 2025, an estimated $69.1K.
  • Group One Trading first reported a position in Tarsus Pharmaceuticals in Q1 2025 and held it in 3 quarters.
  • Group One Trading's Tarsus Pharmaceuticals position peaked at $69.1K in Q3 2025.
  • 246 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.